Trial Profile
Effects of rosuvastatin and sevelamer in coronary calcification in chronic kidney disease patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary) ; Rosuvastatin
- Indications Coronary artery disease
- Focus Therapeutic Use
- 13 Sep 2013 New trial record